CC BY-NC-ND 4.0 · South Asian J Cancer 2020; 09(04): 261
DOI: 10.1055/s-0040-1721178
Letter to the Editor

Gemcitabine in Recurrent Meningioma

Satvik Khaddar
1  Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Arti Bhelekar
1  Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Ochin Dale
1  Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Litty Varghese
1  Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Vijay Maruti Patil
1  Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
› Author Affiliations
FundingNone.
Zoom Image
Dr Vijay M. Patil


Publication History

Publication Date:
15 June 2021 (online)

© 2021. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd
A-12, Second Floor, Sector -2, NOIDA -201301, India